Canada · Federal contract register · Contract

Pharmaceutical and other medicinal products

National DefenceReference C-2022-2023-Q4-00730Procurement W6369-23-A046

Pharmaceutical and other medicinal products — Canada · Federal contract register · Contract: $148.4K contract value ($148,400); No competition how it was bought (no competition); 2022 contract date (27 May 2022).

Assay record ASY-CA-0R0FSMO1VN · Cite as: Assay Systems, “Pharmaceutical and other medicinal products · National Defence · Emergent Biosolutions Canada Inc.”, https://assay-systems.com/register/ca/contract/c-2022-2023-q4-00730/

$148.4K
contract value
$148,400
No competition
how it was bought
no competition
2022
contract date
27 May 2022

The contract

DepartmentNational Defence
SupplierEmergent Biosolutions Canada Inc.
Contract date27 May 2022
Period31 May 2022 – 30 June 2023
Value$148,400
ProcedureNon-competitive (no competition)
Bids receivednot stated
Economic object code1132

One supplier, no rival

The department awarded it without a competition. Emergent Biosolutions Canada Inc. took $148,400 with no other bid on the table.

Source

Proactive disclosure of contracts over $10,000, Government of Canada, open.canada.ca, under the Open Government Licence – Canada. Where a contract was amended, the page carries the last report filed for it.

Contains information licensed under the Open Government Licence – Canada.Source: Government of Canada proactive disclosure of contracts.